Bilastine: all 22 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.CompletedNCT03479307Phase 3Results posted
- A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® ModelCompletedNCT03231969Phase 2Results posted
- Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and AsthmaCompletedNCT02761252Phase 4Results posted
- Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or UrticariaCompletedNCT02576041Phase 4Results posted
- Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in ChildrenCompletedNCT04810390Phase 3
- Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese PopulationStatus unknownNCT03633760Phase 1
- Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or LoratadineCompletedNCT02513290Phase 4
- Bilastine Updosing in Chronic Spontaneous UrticariaCompletedNCT02213367Phase 3
- Evaluation of the Inhibitory Effect of 5 Anti-Histamines in UrticariaCompletedNCT01940393Phase 4
- Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic RhinitisCompletedNCT01400828Phase 3
- Bilastine Updosing - Characterization of Underlying MechanismsCompletedNCT01271075Phase 2/3
- Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety ExtensionCompletedNCT01127620Phase 3
- Oral Bioavailability of BilastineCompletedNCT01124123Phase 1
- A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With BilastineCompletedNCT01108783Phase 3
- Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)CompletedNCT01081574Phase 1/2
- Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SARCompletedNCT00574379Phase 2
- PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)CompletedNCT00574210Phase 2
- Human Mass Balance Study With BilastineCompletedNCT00572611Phase 1
- Efficacy Study for the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00504933Phase 3
- Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic UrticariaCompletedNCT00421109Phase 3
- A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge ChamberCompletedNCT00420082Phase 2
- A Randomized, Multiple Dose, Double Blind, 5-way Crossover Study of the Electrocardiographic (ECG) Effects of BilastineCompletedNCT00419783Phase 1